H.C. Wainwright Reiterates Buy Rating on IO Biotech, Keeps PT at $14
IO Biotech, Inc. (NASDAQ:IOBT) is one of the 11 Low Price High Volume Stocks to Buy According to Analysts. On August 15, H.C. Wainwright reiterated a Buy rating on IO Biotech, Inc.
Io Biotech Inc. (IOBT)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.39 | 15,000 | $20,884.50 | 15,000 | 2025-05-30 | Filing | |
| $0.85 | 31,350 | $26,553.45 | 31,350 | 2024-12-23 | Filing | |
| $0.81 | 12,500 | $10,120.00 | 49,891 | 2024-12-23 | Filing | |
| $0.83 | 10,250 | $8,482.90 | 84,632 | 2024-12-23 | Filing | |
| $0.81 | 12,000 | $9,720.00 | 16,938 | 2024-12-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.31 | 23,478 | $30,786.70 | 4,354,449 | 2024-07-26 | Filing | |
| $1.33 | 51,522 | $68,338.78 | 4,377,927 | 2024-07-25 | Filing | |
| $1.22 | 658,809 | $802,495.24 | 4,429,449 | 2024-05-10 | Filing | |
| $1.50 | 658,809 | $988,411.14 | 5,088,258 | 2024-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
11 Low Price High Volume Stocks to Buy According to Analysts
In this article, we will take a look at the 11 Low Price High Volume Stocks to Buy According to Analysts.
Hedge Fund Resource Center